We analyzed 181 artificial intelligence startups impacting drug discovery.
For this blog, we have selected 3 top startups and analyze their patent and market activities.
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Uses AI to Screen and reposition known drugs in unrelated indications at new, lower doses. Allows researchers to: Identify synergistic combinations of repositioned drugs for diseases with high unmet medical needs. Founded: 2007.
Headquarters: Issy-les-moulineaux, Ile-de-France, France.
Pharnext has raised over €36.5 million since April 2018.
Biodesix is a molecular diagnostics company engaged in the development of innovative products for personalized medicine.
Uses AI to: Uncover clinically relevant blood-based biomarker patterns and relationships.
Allows researchers to: Enable personalized approaches to therapy selection and a better understanding of complex diseases.
Syntekabio is a Korean biotech firm, developing a personal genome map that is expected to enable personalized medical service.
Uses AI to: Analyze genomic data related to cancer and other diseases.
Allows researchers to Discover biomarkers associated with drug responses.
The Innovation Rate graph shows the annual patenting trend in the technology field. When we look at the 2011- 2019 period for the selected companies, we've identified over a hundred patents.
Where they protect?
The territory map shows the breakdown of patents across jurisdictions on the subject technology field. The territory map is a useful visual tool that shows key markets where patent applicants on the subject technology field focus on.
Analyze the technology focus of the selected organizations. Visual shows the presence of the organizations in different technology fields. It helps you to understand where organizations invest to build their portfolio.
Register now to see all organizations and make your own interactive analysis.
Watch the video to learn how innovationradar.com works